Compare GBLI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBLI | CGC |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.1M | 389.2M |
| IPO Year | 2010 | 2023 |
| Metric | GBLI | CGC |
|---|---|---|
| Price | $23.75 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.5K | ★ 2.3M |
| Earning Date | 11-04-2026 | 11-06-2026 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $450,098,000.00 | $12,759,000.00 |
| Revenue This Year | $6.60 | $18.83 |
| Revenue Next Year | $13.62 | $7.72 |
| P/E Ratio | $23.31 | ★ N/A |
| Revenue Growth | ★ 2.02 | N/A |
| 52 Week Low | $22.83 | $0.64 |
| 52 Week High | $30.50 | $2.38 |
| Indicator | GBLI | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 34.07 |
| Support Level | $22.83 | N/A |
| Resistance Level | $28.94 | $1.15 |
| Average True Range (ATR) | 0.67 | 0.04 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 34.98 | 35.61 |
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.